Lamivudine

Form: Tablet

Strength: 100 mg, 150 mg, 300 mg

Reference Brands: Epivir®, Epivir-HBV® (US & EU)

Category: Hepatitis

Lamivudine Tablets are antiviral medications primarily used to treat chronic Hepatitis B virus (HBV) infection and HIV-1 as part of combination therapy. As a nucleoside reverse transcriptase inhibitor (NRTI), Lamivudine effectively suppresses viral replication, reducing liver inflammation and disease progression. Available in 100 mg tablets for hepatitis B and 150–300 mg for HIV, it is widely prescribed and globally trusted. Manufactured under stringent EU-GMP and USFDA standards, Lamivudine is an essential product in hospital procurement and pharma B2B export portfolios. Its proven safety, cost-effectiveness, and global demand make it a key antiviral in the EU and US healthcare markets.